Press Releases

Latest Press Releases for Monteris Medical

Date Title
06/01/2017 Monteris Medical Raises $26.6 Million in Series C Financing to Further the Growth of the NeuroBlate® System
04/26/2017 Monteris Medical Announces New Data from Clinical Studies Evaluating Laser Interstitial Thermal Therapy for Brain Lesions
10/13/2016 Monteris Medical Reaches Milestone For Neuroblate System
09/01/2016 Monteris Medical Receives IDE Approval from FDA to Evaluation Neuroblate® in Patients Newly Diagnosed with Glioblastoma Multiforme
07/19/2016 Monteris Medical Announces Appointment of Martin J. Emerson as President and Chief Executive Officer
05/4/2016 New Data Supporting Clinical Utility of Laser Interstitial Thermal Therapy (LITT) for Brain Lesions Presented at AANS 2016
04/28/2016 Dr. Mark Torchia and Richard Tyc Receive Canadian Governor General’s Innovation Award
04/07/2016 Monteris Medical Receives IDE Approval From the FDA to Evaluate NeuroBlate® in Patients with Medically Refractory Epilepsy
03/14/2016 Monteris Medical Announces New Corporate HQ in Plymouth to Accommodate Rapid Growth and Expansion
10/01/2015 Dr. Mark Torchia and Richard Tyc Receive $100,000 Ernest C. Manning Principal Innovation Award for Co-Inventing the NeuroBlate® System.
09/29/2015 Monteris Medical Announces Data Reinforcing Clinical Efficacy of NeuroBlate Laser Ablation in Patients with Brain Lesions
08/11/2015 Monteris Medical Appoints James Reinstein to its Board of Directors
06/11/2015 Monteris Medical Wins Gold 2015 Medical Design Excellence Award for NeuroBlate® System
05/01/2015 Monteris Medical Announces Launch of FDA-Cleared Neuroblate® Sidefire™ Select™ and Fullfire™ Select™ Reduced Diameter Laser Mini-Probes
04/15/2015 Leading Neurosurgeons Speaking on Clinical Utility of Real-Time Navigated Laser Therapy for Lesion Ablation within Intraoperative MRI Suites at AANS
02/20/2015 First Use of NeuroBlate® From Monteris Medical in Canada
11/13/2014 Monteris Medical Announces $30 Million Equity Financing
10/1/2014 Health Canada Issues Medical Device License for Monteris Medical’s NeuroBlate® System
9/10/2014 Monteris Medical Reaches Milestone for NeuroBlate® System: More Than 275 Procedures Performed at Top Medical Centers Across the U.S.
6/1/2014 Monteris Medical’s NeuroBlate® System for Minimally-Invasive Ablation of Brain Lesions to be Presented at Annual Neurosurgery Meeting
5/20/2014 Collaborations in Neurosurgery: MRI Interventions’ ClearPoint System and Monteris Medical’s NeuroBlate® System Utilized Jointly to Enable Laser Ablation of Brain Tumor
5/13/2014 Monteris MRI Compatible AtamA Stabilization System Available in North America
4/26/2013 Monteris® Medical First-In-Humans Trial Published
4/8/2013 Monteris Medical’s NeuroBlate® System Receives 510(k) Clearance
3/26/2013 Monteris® Medical’s AutoLITT®- NeuroBlate® System for Brain Tumors Receives Regulatory Approval in Canada
12/20/2012 Monteris Medical Announces $7.8 Million Financing
12/10/2012 Monteris® Medical Announces Appointment of Greg Barrett as Board Chairman
12/4/2012 Monteris Medical’s NeuroBlate® System Selected by Lifescience Alley:  Winner of New Technology Showcase
4/24/2011 Monteris Medical, Inc. Secures $9 Million Financing Funding Directed to Expand Development of New Technology Platforms Throughout North America